216 related articles for article (PubMed ID: 37047013)
21. NF90/NFAR (nuclear factors associated with dsRNA) - a new methylation substrate of the PRMT5-WD45-RioK1 complex.
Cox J; Esser LM; Jüdt M; Schmitz K; Reiffert K; Grimmler M; Stork B; Wesselborg S; Peter C
Biol Chem; 2022 Sep; 403(10):907-915. PubMed ID: 36040368
[TBL] [Abstract][Full Text] [Related]
22. Glutathionylation Decreases Methyltransferase Activity of PRMT5 and Inhibits Cell Proliferation.
Yi M; Ma Y; Chen Y; Liu C; Wang Q; Deng H
Mol Cell Proteomics; 2020 Nov; 19(11):1910-1920. PubMed ID: 32868396
[TBL] [Abstract][Full Text] [Related]
23. Human protein arginine methyltransferases (PRMTs) can be optimally active under nonphysiological conditions.
Lowe TL; Clarke SG
J Biol Chem; 2022 Sep; 298(9):102290. PubMed ID: 35868559
[TBL] [Abstract][Full Text] [Related]
24. PRMT5 and Tip60 Modify FOXP3 Function in Tumor Immunity.
Goel PN; Grover P; Greene MI
Crit Rev Immunol; 2020; 40(4):283-295. PubMed ID: 33426818
[TBL] [Abstract][Full Text] [Related]
25. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
[TBL] [Abstract][Full Text] [Related]
26. The macromolecular complexes of histones affect protein arginine methyltransferase activities.
Fulton MD; Cao M; Ho MC; Zhao X; Zheng YG
J Biol Chem; 2021 Oct; 297(4):101123. PubMed ID: 34492270
[TBL] [Abstract][Full Text] [Related]
27. Targeting Arginine Methyltransferase PRMT5 for Cancer Therapy: Updated Progress and Novel Strategies.
Zheng J; Li B; Wu Y; Wu X; Wang Y
J Med Chem; 2023 Jul; 66(13):8407-8427. PubMed ID: 37366223
[TBL] [Abstract][Full Text] [Related]
28. Unique Features of Human Protein Arginine Methyltransferase 9 (PRMT9) and Its Substrate RNA Splicing Factor SF3B2.
Hadjikyriacou A; Yang Y; Espejo A; Bedford MT; Clarke SG
J Biol Chem; 2015 Jul; 290(27):16723-43. PubMed ID: 25979344
[TBL] [Abstract][Full Text] [Related]
29. Targeting protein arginine methyltransferase 5 in disease.
Richters A
Future Med Chem; 2017 Nov; 9(17):2081-2098. PubMed ID: 29076773
[TBL] [Abstract][Full Text] [Related]
30. PRMT5 activates AKT via methylation to promote tumor metastasis.
Huang L; Zhang XO; Rozen EJ; Sun X; Sallis B; Verdejo-Torres O; Wigglesworth K; Moon D; Huang T; Cavaretta JP; Wang G; Zhang L; Shohet JM; Lee MM; Wu Q
Nat Commun; 2022 Jul; 13(1):3955. PubMed ID: 35803962
[TBL] [Abstract][Full Text] [Related]
31. Proteomics profiling of arginine methylation defines PRMT5 substrate specificity.
Musiani D; Bok J; Massignani E; Wu L; Tabaglio T; Ippolito MR; Cuomo A; Ozbek U; Zorgati H; Ghoshdastider U; Robinson RC; Guccione E; Bonaldi T
Sci Signal; 2019 Apr; 12(575):. PubMed ID: 30940768
[TBL] [Abstract][Full Text] [Related]
32. Tumor necrosis factor (TNF)-α induction of CXCL10 in endothelial cells requires protein arginine methyltransferase 5 (PRMT5)-mediated nuclear factor (NF)-κB p65 methylation.
Harris DP; Bandyopadhyay S; Maxwell TJ; Willard B; DiCorleto PE
J Biol Chem; 2014 May; 289(22):15328-39. PubMed ID: 24753255
[TBL] [Abstract][Full Text] [Related]
33. Molecular basis for substrate recruitment to the PRMT5 methylosome.
Mulvaney KM; Blomquist C; Acharya N; Li R; Ranaghan MJ; O'Keefe M; Rodriguez DJ; Young MJ; Kesar D; Pal D; Stokes M; Nelson AJ; Jain SS; Yang A; Mullin-Bernstein Z; Columbus J; Bozal FK; Skepner A; Raymond D; LaRussa S; McKinney DC; Freyzon Y; Baidi Y; Porter D; Aguirre AJ; Ianari A; McMillan B; Sellers WR
Mol Cell; 2021 Sep; 81(17):3481-3495.e7. PubMed ID: 34358446
[TBL] [Abstract][Full Text] [Related]
34. KSHV encoded ORF59 modulates histone arginine methylation of the viral genome to promote viral reactivation.
Strahan RC; McDowell-Sargent M; Uppal T; Purushothaman P; Verma SC
PLoS Pathog; 2017 Jul; 13(7):e1006482. PubMed ID: 28678843
[TBL] [Abstract][Full Text] [Related]
35. Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells.
Mongiardi MP; Savino M; Bartoli L; Beji S; Nanni S; Scagnoli F; Falchetti ML; Favia A; Farsetti A; Levi A; Nasi S; Illi B
Sci Rep; 2015 Nov; 5():15494. PubMed ID: 26563484
[TBL] [Abstract][Full Text] [Related]
36. Arginine methyltransferase PRMT5 negatively regulates cGAS-mediated antiviral immune response.
Ma D; Yang M; Wang Q; Sun C; Shi H; Jing W; Bi Y; Shen X; Ma X; Qin Z; Lin Y; Zhu L; Zhao Y; Cheng Y; Han L
Sci Adv; 2021 Mar; 7(13):. PubMed ID: 33762328
[TBL] [Abstract][Full Text] [Related]
37. Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5).
Palte RL; Schneider SE; Altman MD; Hayes RP; Kawamura S; Lacey BM; Mansueto MS; Reutershan M; Siliphaivanh P; Sondey C; Xu H; Xu Z; Ye Y; Machacek MR
ACS Med Chem Lett; 2020 Sep; 11(9):1688-1693. PubMed ID: 32944135
[TBL] [Abstract][Full Text] [Related]
38. Effects of substrate modifications on the arginine dimethylation activities of PRMT1 and PRMT5.
Fulton MD; Dang T; Brown T; Zheng YG
Epigenetics; 2022 Jan; 17(1):1-18. PubMed ID: 33380261
[TBL] [Abstract][Full Text] [Related]
39. ROS inhibits RORα degradation by decreasing its arginine methylation in liver cancer.
Im H; Baek HJ; Yang E; Kim K; Oh SK; Lee JS; Kim H; Lee JM
Cancer Sci; 2023 Jan; 114(1):187-200. PubMed ID: 36114756
[TBL] [Abstract][Full Text] [Related]
40. OXR1A, a Coactivator of PRMT5 Regulating Histone Arginine Methylation.
Yang M; Lin X; Segers F; Suganthan R; Hildrestrand GA; Rinholm JE; Aas PA; Sousa MML; Holm S; Bolstad N; Warren D; Berge RK; Johansen RF; Yndestad A; Kristiansen E; Klungland A; Luna L; Eide L; Halvorsen B; Aukrust P; Bjørås M
Cell Rep; 2020 Mar; 30(12):4165-4178.e7. PubMed ID: 32209476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
